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Although accumulation of molecular damage is suggested to be an important molecular mech-
anism of aging, a quantitative link between the dynamics of damage accumulation and mortality
of species has so far remained elusive. To address this question, we examine stability properties
of a generic gene regulatory network (GRN) and demonstrate that many characteristics of aging
and the associated population mortality rate emerge as inherent properties of the critical dynamics
of gene regulation and metabolic levels. Based on the analysis of age-dependent changes in gene-
expression and metabolic profiles in Drosophila melanogaster, we explicitly show that the underlying
GRNs are nearly critical and inherently unstable. This instability manifests itself as aging in the
form of distortion of gene expression and metabolic profiles with age, and causes the characteristic
increase in mortality rate with age as described by a form of the Gompertz law. In addition, we
explain late-life mortality deceleration observed at very late ages for large populations. We show
that aging contains a stochastic component, related to accumulation of regulatory errors in tran-
scription/translation/metabolic pathways due to imperfection of signaling cascades in the network
and of responses to environmental factors. We also establish that there is a strong deterministic
component, suggesting genetic control. Since mortality in humans, where it is characterized best,
is strongly associated with the incidence of age-related diseases, our findings support the idea that
aging is the driving force behind the development of chronic human diseases.
Introduction
Aging is a complex biological process. It occurs at
every possible scale characterizing the living organism,
ranging from the single cell level (e.g., oxidative damage,
somatic mutations) to the level of interaction between dif-
ferent organs (e.g., failure of individual organs with age
or accumulation of dangerous byproducts of metabolic
activity such as arterial plaque). This is why it has been
notoriously difficult to pinpoint the ultimate cause, a sin-
gle molecular mechanism behind aging and relate it to
such life-long consequences as the onset and progression
of age-related diseases and, finally, death. As a conse-
quence, a wide spectrum of propositions on the origin of
aging has emerged over the years such as theories that
view aging as a pre-programmed process [1, 2], various
concepts involving damage accumulation [3–7], hyper-
function theory [8–10], disposable soma theory [11, 12],
antagonistic pleiotropy [13] and mutation accumulation
theory [14]. Since the theories of aging often differ greatly
from each other both in spirit and letter and reflect upon
different “facets” of aging [5, 6, 15, 16], it is not always
possible to see their mutual inconsistencies and compat-
ibilities.
One of the key ideas in the study of aging is the causal
role of molecular damage. Over 40 years ago Leslie Orgel
proposed an attractive damage-based theory[7], in which
he argued that molecular corruption of enzymatic ma-
chinery of transcription and/or translation would pro-
duce positive feedback, leading to an “error avalanche”.
We recently proposed a more general hypothesis of er-
ror accumulation[17], supported by a semi-quantitative
stability assessment for a generic gene regulatory net-
work (GRN). We suggested a causal role of regulatory-
error accumulation in the age-dependent increase in mor-
tality rate, reflecting limited ability of cellular damage-
response pathways to repair the consequences of inter-
nal or external stresses However, no underlying mecha-
nism has been established thus far, for the interplay be-
tween the dynamics of error accumulation in transcrip-
tion/translation/metabolic processes and the increase in
mortality rates.
To identify such a link, here we develop a theory of
GRN stochastic critical dynamics and show that under
very generic assumptions GRNs of most species should
be inherently unstable in order to be compatible with
age-dependent behaviour of mortality rates. Apply-
ing the method of proper orthogonal decomposition [18]
to the publicly available age-dependent transcriptome
and metabolome datasets of Drosophila melanogaster
[19, 20], we demonstrate explicitly that autocorrelation
functions of transcriptional and metabolic datasets for
2D. melanogaster exhibit stochastic exponential instabil-
ity with a characteristic time scale, tα, which is of the
same order as mortality rate doubling time tMRDT of
D. melanogaster. We provide explicit solutions for the
stochastic aging dynamics of realistic GRNs to obtain ex-
pressions for the age-dependent mortality increase. We
argue that the two time scales, tα and tMRDT, should
coincide for any species in which mortality follows the
Gompertz equation. We are thus able to causally re-
late GRN instability to the characteristic Gompertzian
increase of the mortality rate in populations. The expo-
nential increase of mortality eventually slows down and
the mortality rate is expected to approach a plateau,
M(t & tls) ∼ 1/tMRDT, at late ages. The result should
be valid for sufficiently long lived species, tls ≫ tα.
The prediction is confirmed by quantative analysis of
the transcriptomes, metabolomes and mortality curves
for populations of D. melanogaster and mortality curves
for very large cohorts of medflies [21]. We establish spe-
cific metabolites and genes as biomarkers of aging in D.
melanogaster, examine the respective human orthologs,
and provide their associations with genes and pathways
commonly related to the major human chronic diseases.
We show that the dynamics of aging, as mani-
fested in transcriptional and metabolic profiles, can
be decomposed into both stochastic component, re-
lated to regulatory error accumulation in transcrip-
tion/translation/metabolic pathways, and strong deter-
ministic component, which can be naturally associated
with a genetic program of an organism. We show that
the presented model may serve to embrace most of the
known features of the aging processes and hence provides
a novel and universal basis for quantitative analysis of di-
verse age-dependent processes. We believe that the theo-
retical ideas presented in the paper could be useful in the
identification of biomarkers and, after appropriate devel-
opment, in mechanistic studies of processes that regulate
aging in any sufficiently long-lived organism.
RESULTS
Critical dynamics of Gene Regulatory Networks:
quantitative model of aging
In this Section, we first explain the theoretical basis of
our quantitative analysis of transcriptional and metabolic
profile changes with age and construct a quantitative
model of aging. We consider the case of the GRN de-
scribed by a generic set of non-linear matrix equations of
systems biology
g
(
x, dx/dt, d2x/dt2, ...
)
= F.
Here g is a vector function of any number of quanti-
ties representing the state of the system, x, and its time
derivatives which characterize the interactions between
different components of x. If, for example, the state vec-
tor x consists of the gene expression levels only, e.g. as in
[19], the function g may be thought of as encoding path-
ways to which the given genes contribute. In addition
to gene expression levels, the state vector x may include
other descriptors, such as levels of metabolites [20] or
methylation levels in DNA [22]. As the system state vec-
tor x is not observable in its entirety, we presume that
any sufficiently large part of it captures representative
information about “macroscopic” properties of the bio-
logical system state at the organismal level. For the sake
of simplicity, below we will refer to gene expression only,
if not stated otherwise.
The vector F describes the action of external or inter-
nal stress factors affecting components of x. The vector
F may depend on time, t: F (t) = F0 + δF (t), where F0
and δF represent the mean stress and the fluctuations of
stress levels, respectively.
Over long times, gene expression levels typically fluc-
tuate near certain, relatively slowly changing, mean val-
ues, corresponding to the average homeostatic state of
an organism. Therefore, we assume that there is always
a quasi-stationary point x0 (homeostasis of the organ-
ism), given by the solution of the stationary equation
f(x0) = F0. As a result, the slow dynamics of the fluc-
tuations of the gene expression levels, δx = x− x0, in its
leading order obeys thе matrix stochastic equation for a
linear continuum-limit of a Markov chain:
Dδx˙+Kδx = δF, (1)
where the matrices D and K describe the dynamical re-
laxation properties and the interactions between the com-
ponents of the gene regulatory network, respectively (see
Supplementary Information, Section A, for in-depth dis-
cussion of Eq.(1) derivation).
It has been previously suggested that, in most species,
GRNs operate close to a stability-instability transition
or order-disorder bifurcation [17, 23, 24]. The transition
from stability to instability in networks with the network
graphs not possessing specific symmetries is typically as-
sociated with occurrence of co-dimension 1 bifurcations
[25, 26]. Such transitions are characterized by the loss
of stability along a single direction in the state vector
space, corresponding to the first principal component,
while contributions from all other principal components
remain stable. This situation, known in the literature
as a saddle-node bifurcation [25], is realized when the
smallest real eigenvalue, ǫ, of the matrix K tends to zero,
ǫ→ 0, and then becomes negative. Accordingly, the sta-
tionary solution for x0 ceases to exist, and the homeo-
static state of the organism starts to change in time. As
we shall argue, this very instability is directly responsible
for the process of aging.
To be specific, hereinafter we focus on this scenario.
As explained in Supplementary Information, Appendix
A, the derivative δx of any gene expression level becomes
critical close to the co-dimension 1 bifurcation point.
This implies that fluctuations of the expressome δx are
strongly amplified with age, the phenomenon known as
critical slowing-down (see e.g. [27]). In particular, the
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Figure 1: (A) Schematic representation of the stochastic dynamics in the effective potential V (z) corresponding to
the cases of unstable (α > 0) and stable (α < 0) GRNs, see Eq.(2). (B) Age dependence of z1,2 = (δx
T · b1,2) of the
expressome state projections onto the vectors b1,2 corresponding to the first two principle components as functions
of age (gene expressions for normally fed D. melanogaster from [19], red, and metabolite levels for normally fed D.
melanogaster from [20], blue). Here E(...) stands for the average over the biological repeats; (aT · b) denotes a scalar
product of two vectors a and b.
autocorrelation time scale tauto = (a
T ·Db)/ǫ of the ex-
pressome diverges as ǫ → 0, indicating that stochastic
dynamics of δx is very slow near the point of bifurca-
tion. The fluctuations of the expressome state vector δx
including those created in response to persistent external
stress, are mostly amplified along the direction b of the
right eigenvector of matrix K corresponding to the van-
ishing eigenvalue ǫ. The latter observation is supported
by the analysis of experiments in D. melanogaster, where
transcriptional responses to different stress factors were
found to contain a good fraction of similar differentially
expressed genes in the limit of both nearly lethal [28] and
weak stressors [29].
Accordingly, over times comparable to the average
lifespan, the gene expression fluctuations are dominated
by transcript-level changes along the vector correspond-
ing to the leading principal component, which is collinear
with the direction of the vector b. We conclude that for
long time intervals evolution of the vector of the GRN
state vector, δx, can be accurately described using a sin-
gle variable z, such that δx ≈ z · b. Accordingly, Eq.(1)
can be reduced to the equation
dz
dt
+
∂V (z)
∂z
= f, (2)
describing the Brownian motion of a particle in an ef-
fective potential V (z) ≈ −αz2/2, for sufficiently small
z, and the quantity α = −ǫ/(aT · Db) characterizes the
“stiffness” of the gene regulatory network. The stochastic
force, f = (aT · δF )/(aT · Db), is a single unified quan-
titative measure of stochastic component of all external
and internal stress, and is characterized by the diffusion
coefficient ∆ (see Supplementary Information, Appendix
A for the in-depth derivation and necessary justification).
Depending on the specific morphological properties of
the gene regulatory network, the curvature of V (z) at
small z can be negative, α < 0, or positive, α > 0, as
shown in Figure 1A. The first case will be briefly consid-
ered in Discussion section. In the latter case, the GRN
is inherently unstable, and the variance of gene expres-
sion levels, C(t), computed using the solutions of Eq.(2),
grows exponentially with age as
C(t) = E(δx(t)δxT (t)) ≈ E(δx20)b · bT exp(2αt). (3)
The expression (3) is fully consistent with earlier observa-
tion of increasing biological variability with age [30, 31].
Criticality of gene expression-level dynamics criticality
implies that the parameter α is close to zero and hence
the expressome covariance matrix C(t) should be a ma-
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Figure 2: Basic biological evidence for the presented stochastic model of aging: (A) Mortality rate along with the
projection z of the system state vector, δx, represented by the transcriptomes of aging D. melanogaster [19], onto
the singular direction b of the covariance matrix E(δx(t)δxT (t′)) as a function of age. (B) Components of the vector
b for D. melanogaster. Peaks correspond to the values of the components of the vector b for every gene in the
dataset. (C) Mortality rate and the projection z of the system state vector δx, represented by the metabolomes of
D. melanogaster as a function of age [20]; (D) Components of the vector b for D. melanogaster, computed using only
the levels of targeted metabolites [20].
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Figure 3: Biological characterization of the “leading direction of aging” b in D. melanogaster : (A) Gene Ontologies
(Biological Process only) enrichment by the leading positive and negative components of the vector b computed
using gene expression transcripts; (B) KEGG pathways enrichment for human orthologs of the gene sets
representing the leading components of b, corresponding to positively and negatively regulated genes.
trix with special structure. Eq.(3) implies that in this
case the right eigenvector of the covariance matrix corre-
sponding to its largest eigenvalue coincide with the right
eigenvector b of the matrix K corresponding to vanishing
eigenvalue ǫ → 0 (see Supplementary Information, Ap-
pendix A). What is more, the largest eigenvalue should be
much larger than all other eigenvalues of this matrix. In
reality the properties of the experimental sample covari-
ance matrix may be degraded by the experimental noise
and necessarily very limited number of samples compared
to the number of transcripts or metabolites observed.
These conclusions are supported by Principal Com-
ponent Analysis (PCA) of the age-dependent shifts of
RNA-transcript and metabolite levels in normally fed D.
melanogaster from [19] and [20], respectively. The covari-
ance matrices computed from such datasets are indeed
almost singular, see Supplementary Information, Figure
4. Correspondingly, the variation of the state vector δx
with age is dominated by the change along the loading
vector corresponding to the first principal component,
and z ≡ z1, where z1 = (δxT · b) is the first princi-
pal component, as described in Figure 1B. The variance
along this vector grows very quickly with age, both in the
metabolome and the transcriptome, in accordance with
Eq.(3). The exponent, roughly inferred from each of the
datasets for ages less than the mean lifespan, appears to
be nearly the same, which is an indication of the same
GRN instability observed in each of the experiments. For
the sake of comparison, we have also plotted projections
of gene expression on the next principal component. It is
easy to see that the transcriptome and metabolome re-
main dynamically stable along the direction of the second
principal component.
We thus hypothesize that at the origin, z ≈ 0, the
expressome state corresponds to a healthy or “youthful”
state, while larger values of z phenotypically describe dis-
torted states of aged animals. Accordingly, aging mani-
fests itself as a slow dynamics of expression levels, an ex-
ponential roll-out along the singular, or “aging” direction
b, from the younger animals to the older ones. The sin-
gular “direction of aging” b is associated with a response
to a generic stress and determined by the properties of
the interactions in the network only. At least within the
model assumptions, the direction b does not depend on
the detrimental stress factors and appears to be hard-
coded in the genome, and hence the development along b
can be considered as an organism-level manifestation of
an aging program or quasi-program [32–35]). The “direc-
tion of aging”, vector b, is similar but not the same as the
differential expression vector in aging animals, since the
latter may include a contribution of faster modes repre-
sented by other eigenvectors of the GRN connectivity ma-
trix K corresponding to eigenvalues with larger absolute
value. Since the network state fluctuations along all the
other directions are not related to aging and are relatively
small, we conclude that the deterministic component of
6aging in δx(t) already dominates over the stochastic one,
even early in life (also see below).
Gompertz mortality law and biological age
To relate the GRN instability to the process of aging
we further assume that for every gene in the genome there
exists a particular threshold associated with its over- or
under-expression, which leads to a strong build-up of
deleterious changes, which in it turn ultimately lead to
death. Since fluctuation of the expression levels can be
written in the form δx ≈ z · b, such deleterious thresh-
olds can be defined by the specific values of z = Zi for
every gene, which may be either positive or negative. It
is reasonable to assume that the death of a cell (and ulti-
mately of an organism) occurs once z reaches the small-
est (by absolute value) of the threshold values, z = Z.
In Supplementary Information Section B we argue, that
as the expressome state deviates from the initial point,
the higher order non-linearities in Eq.(1) and therefore
in the effective potential V (z) of Eq.(2) can no longer be
neglected. As expected from the argument, we are able
to show in Supplementary Information section B, that
the threshold value Z can be equally well introduced for-
mally in the model as the single effective property of the
non-linearity in such a way that Z is large whenever the
non-linear interactions are weak..
Initially, the probability density along the aging direc-
tion is localized at a small value of z and the mortality is
also very small. If severe deleterious changes occur late in
life, i.e. if γ = αZ2/∆ ≫ 1, the lifespan greatly exceeds
tα, the non-linearity is small, and the mortality increases
exponentially with age first, then the growth decelerates,
and, eventually, the mortality reaches a plateau. At in-
termediate ages, in a narrow range close to the average
lifespan of the animals, the mortality can be approxi-
mated with
M ≈ 0.61αeα(t−tls) ∼ ∆
Z2
eαt. (4)
This is a form of the Gompertz law [36] (see Supplemen-
tary Information, Appendix B for the complete analyti-
cal solution for the age-dependent mortality in a closed
form for all ages). The Gompertz exponent α is related
to the Mortality Rate Doubling Time (MRDT), tMRDT,
by equation α = log(2)/tMRDT. In practice, the value
of α is often determined from the survival records at the
age, corresponding to a narrow interval of width ∼ 1/α
around the mean lifespan, when most of the animals die.
Therefore Eq.(4) suggests that the empirical Gompertz
exponent should be very close to the GRN “stiffness”.
On the other hand, the Initial Mortality Rate (IMR),
ΛIMR, is related both to the stress levels and to the time
required to reach the boundary Z under the action of the
random damaging forces only, ΛIMR = ∆/Z
2. Normally,
the stochastic forces are weak, γ ∼ (α/ΛIMR) is large,
and, therefore, average lifespan, E(tls) ∼ α−1 log γ ≫
α−1, is also large compared to the characteristic time,
associated with the gene network instability, tα ∼ α−1.
Remarkably, the lifespan in the model depends on the
morphological properties of the GRN, such as its topol-
ogy and connectivity, through the matrix K, and, more
specifically, through its lowest eigenvalue ǫ ∼ α. The de-
pendence of species lifespan on damaging factors through
the parameter ∆ is, on the contrary, logarithmically
weak. This has been recently shown in analysis of data
from [37] in our work[17], where long-term effects of trau-
matic brain injury at young age led to significant, but
small changes in organismal lifespan. This also means
that the gene-network evolution along the aging direc-
tion is practically deterministic in sufficiently long-lived
organisms. At the same time, the stochastic forces are
still very important early in life, yielding a relatively wide
distribution of transcription profiles even in a group of
otherwise identical animals at birth. Our analysis pro-
poses that the stochastic component of the GRN dynam-
ics explains the distribution of the observed ages at death
in such a cohort.
Mortality in a form similar to Eq.(4) can be associated
with gene network instability in a simple phenomenologi-
cal model, where both IMR and MRDT were expressed in
terms of generic network parameters, such as translation,
gene repair and protein turnover rates, along with the
stress levels, whereas mortality is directly associated with
the increasing number of regulatory errors [17]. There-
fore, the quantitative indicator of the expressome remod-
eling along the aging direction, z, can be interpreted as
a measure of damage accumulated over the lifespan of an
organism.
As we show in Supplementary Information, Appendix
B, the dynamics of gene expression levels δx in the weak
non-linearity, or “Gompertzian” ,limit, γ ≫ 1, proceeds
along a well-defined trajectory, corresponding to a con-
tinuation of the development program. The “distance
traveled” along the aging direction up to current mo-
ment of time, z ∼ (δxT · b), is, according to Eq.(4), di-
rectly related to mortality and hence by itself is a good
biomarker of mortality and aging. These observations
pave the way to define biological “clocks” using any num-
ber of variables characterizing a GRN state. For exam-
ple, Figures 2A & C suggest the possibility of developing
transcriptome- and metabolome-derived biological clocks
for D. melanogaster. Those clocks in turn may be com-
pared with the biomarkers of aging and the biological
age calculator (biological clock) similar to, for example,
the one derived from a regression model established using
age-dependent DNA-methylation patterns [22].
Association between GRN instability and mortality
rate
Our analysis of D. melanogaster age-dependent tran-
scriptional data from [19] indicates that the gene ex-
pression variance grows exponentially with age in agree-
7ment with Eq.(3), with α ≈ 19.1 yr−1, as shown in Fig-
ure 2A. In a similar fashion we have studied the “direc-
tion of aging” b in the metabolome of D. melanogaster
[20]. The projection of the metabolome state vector onto
the singular direction b increases very quickly with age,
along with the reported mortality as shown in Figure
2C. The mean lifespan of D. melanogaster is about 25
and 40 days in both experiments, respectively, and in
the two cases the initial exponential growth of the pro-
jection z2(t) ceases at t & tls, as predicted by the the-
ory. Figure 1B represents a side-by-side comparison of
the variance computed from the gene expression and the
metabolome datasets. The values of instability rates, α,
recovered from analysis of both experiments, are very
similar and close to the value of the Gompertz exponent
α = ln 2/tMRDT = 17.1 yr
−1 corresponding to the mor-
tality rate doubling time tMRDT ≈ 0.04 yr [38].
The pace of mortality-rate increase slows at
advanced ages
At more advanced ages, t & E(tls), where tls is the
average lifespan of the population, solutions of Eq.(2)
exhibit deceleration of mortality. More specifically, as
shown in Supplementary Information, Appendix B, we
expect that the mortality rate ceases growing and satu-
rates at a constant value, M∞ ∼ α. This quantitative
prediction can be compared with the experimental data
for medflies [21], where the cohort sizes were sufficient
to observe both the regime of exponentially increasing
mortality and the mortality plateau (see Supplementary
Information, Figure 7). For the male medflies we find
the asymptotic valueM∞ ≈ 0.16 day−1, which is close to
the Gompertz exponent α ≈ 0.22 day−1, in accordance
with theoretical prediction. The asymptotic value of the
mortality rate for female medflies, M∞ ≈ 0.12 day−1, is
also of the right order of magnitude, though nearly two
times smaller than the slope of the mortality exponent
α = 0.25 day−1. Nevertheless, there is an approximate
agreement between between the asymptotic value M∞ of
the mortality rate at late ages and the value of the Gom-
pertz exponent α in both cases. We also note that the
approximate Eq.(4) should work better for longer living,
or “Gompertzian”, ΛIMR ≪ α, organisms.
Biomarkers of aging in D. melanogaster
We computed the aging direction based on the tran-
scriptomic data from Drosophila melanogaster [19]. Gene
Ontolology (GO) analysis of the leading components of
b vector is summarized in Figure 3A, for Biological Pro-
cess (BP) categories only. The genes providing the most
significant negative contribution to the aging direction b
can be roughly split into three groups. First, there is
a large group of genes related to metabolic processes:
organophosphate metabolism, generation of precursor
metabolites and energy, membrane and mitochondrial
ion transport. A detailed review of the GO categories in-
volved seems to indicate that most of the down-regulated
processes are related to oxidative phosphorylation or res-
piration. Another large group of genes involves devel-
opmental processes, such as anatomical structure forma-
tion involved in morphogenesis and extracellular struc-
ture organization. Genes encoding eggshell and egg coat
formation correspond to strongly negative components of
the vector b, which points to the reproductive senescence
in female flies. Finally, we observe decline in processes
related to proteostasis, including protein folding, ER lo-
calization and proteolysis.
As expected, the cluster of genes corresponding to the
strongest positive components of the vector b includes
genes associated with a generic stress response. Among
other leading components there are genes corresponding
to the innate immune response (which is also a stress
response), in agreement with previous conclusions [39],
and the components of oxidation-reduction and reactive
oxygen species metabolic processes.
We found that several transcription factors (TF) ap-
pear to be strongly associated with aging. One of the
top positively associated genes, hairy, is a transcrip-
tional suppressor, and believed to be a metabolic switch,
found up-regulated in the gene expression datasets char-
acterizing oxygen-deprived flies. Conversely, mutations
in hairy significantly reduce hypoxia tolerance [40]. The
only negatively associated transcription factor, eve, is a
transcription factor involved in multiple organ and sys-
tem development.
Human orthologs for biomarkers of aging in D.
melanogaster
To obtain a better insight into aging ofD. melanogaster
we annotated gene expression changes involved in aging
in flies with human orthologs. This is possible to do
since according to OrthoDB, approximately 80% of all
genes in D. melanogaster have human orthologs. We
searched for human orthologs of the leading contribu-
tors to the aging direction vector b computed from the
transcriptome of D. melanogaster. The results of this
analysis are represented in Figure 3B. Remarkably we ob-
serve transcriptional changes associated with human age-
related diseases: the downregulated genes were enriched
in KEGG categories corresponding to age-related neu-
rodegenerative diseases (Huntington’s, Parkinson’s and
Alzheimer’s), and also the processes of cardiac muscle
contraction. We also observed that the downregulated
genes enriched in KEGG pathways were associated with
oxidative phosphorylation (consistent with the GO an-
notation and KEGG enrichment results above). In con-
trast, KEGG PPAR signaling pathway is activated with
age, which may be another indication of the activation of
anti-oxidant metabolism systems as noted above. There
is evidence suggesting that PPARα and the genes under
8its control play a role in the evolution of oxidative stress
increases observed in the course of aging in mice [41].
Further evidence relating the stochastic instability of
the gene regulatory network to the common age-related
diseases is a strong positive contribution of the Pepck
gene, which encodes a rate-controlling enzyme of glu-
coneogenesis, the process by which cells synthesize glu-
cose from metabolic precursors. RNAi silencing of the
Pepck gene was found to be an effective way to reverse
diabetes-induced hyperglycemia in mice[42]. It has also
been shown that expression of the Pepck ortholog in
Caenorhabditis elegans correlates almost perfectly with
longevity in an isogenic series of longevity mutants[43].
Also, a transgenic mouse strain constitutively overex-
pressing muscle PEPCK is muscular and long-lived [44].
DISCUSSION
Our analysis suggests that aging involves an organis-
mal level manifestation of the inherent instability of gene
regulatory networks. Proper orthogonal decomposition
of age-dependent transcriptional and metabolite profiles
shows that, for species which age in accordanсe with the
Gompertz equation, the life-long dynamics of the tran-
scriptional and metabolite profiles can be effectively de-
scribed in terms of stochastic critical dynamics with a
single degree of freedom; that dimension/component is
identified by the projection of the expressome on the
right eigenvector b of the GRN connectivity matrix K,
and associated with the eigenvalue ǫ which vanishes at
the critical point. We establish that depending on the
sign of ǫ, a GRN can be either stable or unstable. We fur-
ther propose that changes in metabolite levels contribute
to aging similarly to changes in GRN, e.g., through a
buildup of certain metabolites and molecular damage be-
yond a certain level. We note that appearance of such
deleterious thresholds is guaranteed, if non-linearities in
the equation (1) for expressome levels are accounted for
(see Supplementary Information, Appendix B). We show
that in this limit mortality follows the form of the Gom-
pertz law, i.e. it first increases exponentially with age
and then saturates at a constant level, a prediction sup-
ported by experimental evidence. As predicted, we find
approximate agreement between the rate of gene regula-
tory network instability and the value of mortality rate
saturation. Thus we are able to demonstrate that Gom-
pertzian aging is a property of organisms with inherently
unstable gene regulatory networks, and thus the gene net-
work instability is a process that directly contributes to
aging, which can be observed in the form of an exponen-
tial increase of all-cause mortality with age.
Though stochasticity of the expressome is an essen-
tial part of the model, it should be noted that in the
Gompertzian limit a wide variety of organisms exhibits
similar dynamics of expression profiles. According to our
theory, genetically programmed connectivity matrix K
can be represented by its low-rank approximation using
its right eigenvector b and the corresponding eigenvalue ǫ.
Such a direction can be interpreted as a genetically pro-
grammed mechanism of aging. It is important to note
that this direction is identifiable from experimental data,
thus allowing quantitative predictions to be made about
a mechanism behind aging.
The stochastic model of aging presented here is fully
compatible with, and in fact embraces, several prevailing
theories and hypotheses of aging, in the following sense:
• programmed and quasi-programmed aging
[1, 2, 10]. We have shown that aging-driven dy-
namics of the expressome δx(t) can be separated
into stochastic and deterministic components. The
deterministic component of δx(t) starts to domi-
nate over the stochastic one even early in life, at
roughly the same time as the low-rank approxima-
tion of the GRN connectivity matrix K becomes
prominent, as can be seen from the fact that the
covariance matrix is singular and dominated by the
aging direction. As the dynamics of the expressome
δx(t) is largely determined by the properties of the
matrix K, we interpret the low rank approximation
of K as a program or a quasi-program of aging [8],
though no statement about its evolutionary nature
can be made. We speculate that the same direction
that corresponds to aging occurs and is active dur-
ing development, thus being consistent with quasi-
programmed aging theory.
• hyperfunction theory [8, 9]. The single mode
δx = z · b, describing a large cluster of genes that
make a dominant contribution to the process of ag-
ing, starts dominating the aging dynamics soon af-
ter the completion of development, and the stochas-
tic effects on the expressome dynamics can be con-
sidered relatively weak [8, 9]. The expression of
positive leaders of the aging direction b will grow
with time, which can be interpreted as hyperfunc-
tion. In the model proposed, death of the organism
is associated with a threshold beyond which this or-
ganism dies, which can be interpreted in the man-
ner of hyperfunction theory as excessive functions
of gene products for positive leaders of aging di-
rection. However, some significant differences from
hyperfunction theory as proposed in [8, 9] should
be noted. Namely, we do not have any experimen-
tal data to determine the role of aging direction in
developmental processes so this connection remains
speculative. Moreover, according to the theoretical
model, changes along stable developmental direc-
tions will tend to diminish with time and will not
contribute to changes in gene expression, so at least
some fraction of genes involved in development will
not contribute to aging.
• damage/error accumulation [3–6]. The
stochastic component of the expressome δx(t) can
be interpreted as a result of accumulation of er-
rors, e.g. regulatory errors. Though it becomes
9small compared to the deterministic component at
late ages, its effects are strongly pronounced at all
ages, as the mean square deviation
√
E(δx2(t)) first
grows with age at the same exponential Gompertz
rate as the mortality M(t) and later stabilizes at
some constant level, contributing at late ages to the
very process of organism passing beyond toxicity
threshold and dying. Our analysis shows, that the
stochastic forces shaping the expressome evolution
early in life explain a wide distribution of the ages
at death even in a genetically homogenous popula-
tion. It should be noted that damage accumulation
does not exclude the scenario of quasi-programmed
aging, as damage is not limited to byproducts, er-
rors and other molecular forms, but encompasses
deleterious changes at all levels, or the deleteriome
[5, 6, 16].
The relationship just established between the critical dy-
namics of the gene regulatory network state vector and
the Gompertzian mortality characteristic of most species
allows one to consider the projection z = (bT · δx) as a
candidate biomarker of aging. Due to the low value of the
eigenvalue ǫ the direction b dominates the response to any
generic stress. This, in fact, was already demonstrated
in [29], where transcriptional signatures of responses to
very different stresses were found to share a great number
of gene expression changes.
The levels of gene expression or metabolites corre-
sponding to the most significant components of the ag-
ing direction b are strongly associated with age and age-
related diseases. Therefore aging as described here, in
terms of GRN instability, leads to the impairment of nor-
mal physiological functions, has characteristic biomark-
ers and phenotypes including signs of major diseases of
aging, and produces exponentially increasing morbid-
ity. Accordingly, the process of aging itself falls un-
der the definition of a disease recently used by AMA
for a common condition such as obesity [45]. We must
note here that therapeutic or experimental interventions
aimed to counter-balance the age-related changes in gene
or metabolite expression may not be very effective ways
to extend lifespan of the species. For example, even
though aging in D. melanogaster is associated with in-
creased internal and external bacterial load, as well as
with increased expression of antibacterial peptides, nei-
ther reducing the bacterial population with antibiotics
nor reducing the humoral antibacterial response was able
to extend lifespan [46]. The transcription factor hairy is
overexpressed with age, and yet its inhibition does not
result in lifespan increase [40]. This reinforces the con-
clusion that the markers of aging are, in general, not the
same as regulators of aging.
Even though most of the analysis in this manuscript
is performed for D. melanogaster, our conclusions are
generic and should be applicable to other species. De-
pending on the network and environmental parameters,
realistic GRNs would not necessarily support a deriva-
tion of the Gompertz law. In fact, aging is extremely
diverse across the tree of life [47]. We believe that one of
the most intriguing form of a non-Gompertzian mortality
law in the model may arise if the effective potential V (z)
has a local minimum with small but positive curvature,
as in Figure 1A, α < 0. The higher order nonlinearities,
such as the cubic terms in the effective potential, cannot
be neglected anymore and in this case the genetic network
turns out to be metastable. If the minimum of the poten-
tial V (z) is separated from the region of large z by a suffi-
ciently high activation barrier (see Figure 1A and Supple-
mentary Information, Appendix B), the mortality rate,
determined by the probability of activation, is exponen-
tially small and age-independent. This situation could be
a physical picture behind the hypothesis that some ani-
mal species exhibit negligible senescence [48] This feature
of our model may also explain the apparent lack of age-
dependent changes in physiological parameters as well as
mortality rates observed in the naked mole rat and some
other species over long time periods [49]. This argument
may also be supported by the analysis in [50, 51], where
the number of the genes differentially expressed with age
was compared between extremely long-lived species and
mice and humans. These works show that the number
of differentially expressed genes in species with negligible
senescence is much lower than in mammals with Gom-
pertzian aging.
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SUPPLEMENTARY INFORMATION
Appendix A: Stochastic dynamics of gene expression
and metabolite levels
In the following, we explain the physical basis for Eq.
(2) and provide its derivation. We also explicitly find
the expressions for the mortality rate, the survival prob-
ability, the lifespan distribution function and the average
lifespan of species with expressome subject to Eq. (2).
1. Getting a grasp on expressome dynamics.
Model reduction and physical considerations
The analysis represented in this paper is mainly based
on the observation that time series datasets describ-
ing changes of expressome profiles with age are of-
ten quite susceptible to Model Reduction techniques
[18]. Proper orthogonal decomposition of dynamic (time-
series) datasets for age-associated gene expression lev-
els (and also metabolite levels or other “omics” datasets)
[19, 20, 52] shows that the long-time behavior of any ex-
pressome x is largely determined by a single component
(see Fig. 4). The number of different principal compo-
nents PCn representing the signal x(t1), . . . , x(tm) can-
not not exceed the number of time snapshot points in
corresponding time series. Even though m is typically
limited and is very small compared to the number of
transcripts or metabolites, , the clear dominance of a sin-
gle component in the signal is a non-trivial fact. As we
argue here, it carries important information about bio-
logical gene regulatory and metabolic networks; namely,
it shows that such networks are pre-critical in a sense
that will be explained below.
Consider a meta-stable gene regulatory network
(GRN) with the instantaneous network state represented
by a vector x, whose components xi are given by expres-
sion levels of different genes, proteins or metabolites par-
ticipating in the GRN. Dynamics of the vector x consists
of mRNA levels, concentrations of proteins and metabo-
lites, involved in regulatory pathways and are influenced
by external as well as internal stress factors acting on
the cell. This dynamics is governed by differential ma-
trix equations of systems biology
g
(
x,
dx
dt
,
d2x
dt2
, . . .
)
= F, (A1)
where g is a vector function of the state vector x, en-
coding interactions between different components of the
expressome, and the vector F describes the action of
(mostly stochastic) external or internal stress factors af-
fecting components of x. For the sake of simplicity, below
we will refer to gene expressions only, if not stated oth-
erwise.
Generally speaking, the vector function g may depend
on arbitrarily high time derivatives dxdt ,
d2x
dt2 , . . . ,
dnx
dtn , . . .
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Figure 4: Five largest singular values Si(x(t)) of the
expressome x(t) divided by the largest one, S1(t);
transcriptome of D. melanogaster [19] (blue),
transcriptome of R. norvegicus, hippocampus [52]
(green), metabolome of D. melanogaster, targeted
metabolites only [20] (red), metabolome of D.
melanogaster, all metabolites [20] (purple). One of the
orthogonal components of the expressome x(t) clearly
dominates over the others in all considered cases.
of the expressome state vector. Hereinafter the focus of
the study is on the dynamics of x at time scales compara-
ble to the mortality rate doubling time tMRDT, which is
of the order of tens of days for nematodes and drosophi-
lae and hundreds of days for mice. This time scale is to
be compared to a typical time scale of protein transla-
tion and regulation, or a lifetime of mRNA. In order to
describe this slow dynamics of the expressome state vec-
tor x, one can neglect all time derivatives of x higher the
first derivative dxdt . The matrix Eq. (A1) thus reduces to
g
(
x,
dx
dt
)
= F. (A2)
2. Frequency domain properties of the vector F of
stress factors
As it was explained in the main text, the vector F of
environmental and internal stress factors affecting gene
expression levels x has both a slowly changing compo-
nent, F0(t), and a stochastic component, δF (t), rapidly
changing in time. Below we assume for simplicity that
F0(t) = F0, i.e., the slowly changing component is, in
fact, constant.
Since dynamics of the vector δF can be considered es-
sentially random at time scales of interest, dynamics of
x is driven by correlation properties of δF . The total
number of environmental and internal stress factors af-
fecting gene expression levels x is extremely large, and
the vector δF (t) represents a superposition of these fac-
tors. According to the central limit theorem [53] it can
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thus be considered a Gaussian stochastic process, so that
E(δF (t)δF (t′)) = B(t− t′),
where B(t− t′) is a function of the time difference |t− t′|
only, while E(. . .) stands for the expected value of its ar-
gument. The statistical average is understood as average
over ensemble of species/cells of a given organism. In the
frequency domain, one has correspondingly
E(δF (f)δF (−f)) =
=
ˆ
df e−2piif(t−t
′)E(δF (t)δF (t′)) = B(f),
where f is frequency of a given mode in the Fourier ex-
pansion of the function B(t− t′).
The function B(f) has multiple singularities in the
complex plane of f . These singularities encode charac-
teristic time scales of pathways’ dynamics. However, the
function B(f) decays quickly with f as f → ∞. This
guarantees that the amount of stress affecting the gene
expression levels x does not change very rapidly. On the
other hand, the behavior of B(f) is smooth at very small
frequencies, i.e., B(f)→ B as f → 0, so that the ampli-
tude of rare fluctuations of δF remains limited. As we
would like to understand the dynamics of x at time scales
comparable to tMRDT, we consider the case B(f) ∼ B in
what follows. In this, the stochastic process δF (t) in the
right-hand side of Eq. (A2) has correlation properties of
white noise:
E(δF (t)δF (t′)) = Bδ(t− t′), (A3)
where δ(t− t′) is the Dirac delta-function.
3. The vicinity of a stationary point (homeostasis)
When the fluctuations of the genotoxic forces are rela-
tively weak, |δF | ≪ |F0|, the fluctuations of the expres-
some state vector are also small: x = x0 + δx, δx≪ x0.
Here x0 is the stationary point given by the solution of
the equation
g(x0) = F0.
In the vicinity of this point Eq. (A2) reduces to
Dδx˙+Kδx+ Γ(3)δxδx+ . . . = δF, (A4)
where the matrices D and K describe the relaxation ef-
fects and the “interaction” between genes in the GRN.
The matrix Γ(3) encodes the leading non-linear terms in
the expansion of the vector function g(x) in powers of
small δx, with all other terms corresponding to the higher
order non-linearities being omitted from the expansion.
Generally, such non-linear terms are not small (in partic-
ular, they are not small at early times, close to the initial
state of the expressome). However, a common feature of
the dissipative network described by Eq. (A4) is the de-
cay of (most) components of δx with time, which makes
non-linearities in Eq. (A4) less relevant at later stages of
the time dynamics. Whether this feature holds for the
GRN under consideration is a non-trivial question, which
we shall now address.
4. Saddle-node bifurcation and critical
slowing-down
Domination of a single principle component in the ex-
pressome vector x(t) is not a generic prediction of the
model (A4). We would like to argue that such a domi-
nance implies that GRNs under consideration are oper-
ating at the critical point. This critical point is a bifurca-
tion, separating regimes of stable and unstable run-away
behavior of the expressome δx.
Transition from stability to instability in networks with
network graphs not possessing specific symmetries is typ-
ically associated with existence of co-dimension 1 bifur-
cations [25, 26]. Such transition is characterized by the
loss of stability along a single orthogonal component of
the network state vector. Contributions from all other
orthogonal components remain stable. This situation is
known in the literature as saddle-node bifurcation [25]
and is realized when the lowest (real) eigenvalue of the
matrix K reaches zero and then becomes negative.
Let us denote the smallest (vanishing, but positive)
eigenvalue of the matrix K as ǫ and its corresponding
left and right eigenvectors as a and b. In order to under-
stand dynamics of the expressome δx near the GRN bi-
furcation, it is convenient to analyze the autocorrelation
function E(δx(t)δx(t′)). As shown in [54, 55], the lat-
ter is given by the following expression (in the frequency
domain)
E(δx(t)δxT (t′)) =
=
ˆ
df · e−2piif(t−t′)A−1(f)E(δF (−f)δFT (f))A∗,−1(f),
(A5)
where A(f) = i2πDf + K. Its behavior is determined
by the poles of the integrand in the complex plane of
frequency f . In turn, the latter are given by the solution
of the equation
det(A(f)) = 0,
i.e., by the solution of the eigenvalue problem for the
matrix ±i(2π)−1D−1K. In particular, at very large time
separations |t− t′| one finds that
E(δx(t)δxT (t′)) ≈ (a
T ·Ba)b · bT
ǫ(aT ·Db)3 exp
(
− ǫ|t− t
′|
(aT ·Db)
)
.
(A6)
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Several important observations can be made at this point:
1) as the parameter ǫ approaches 0, amplitude of the au-
tocorrelation function (A6) grows as ǫ−1, i.e. fluctuations
of the expressome vector are strongly amplified both with
age and among the population (the statistical ensemble);
2) the autocorrelation time scale τ = (aT · Db)/ǫ also
grows strongly at ǫ→ 0, implying that stochastic dynam-
ics of the expressome becomes very slow near the point
of bifurcation, a phenomenon known as critical slowing-
down (see for example [27]); 3) fluctuations of the ex-
pressome vector δx mostly develop along the direction b
of the right eigenvector of K corresponding to the van-
ishing eigenvalue ǫ, which in its turn guarantees that a
single principal component of the expressome vector δx
dominates; 4) the corresponding left eigenvector a deter-
mines directions of high sensitivity of the expressome to
genotoxic stress factors δF . Other remaining eigenvalues
of −i(2π)−1D−1K have strictly positive real parts and
thus correspond to contributions to (A6), rapidly decay-
ing with time. This guarantees that only one orthogonal
component of δx dominates, in accordance with experi-
mental observations.
It should be noted that, when higher order derivatives
in Eq. (A1) are taken into account, this argument, al-
beit becoming more involved, remains valid: one has to
construct the perturbation theory in powers of small pa-
rameter ǫ, which still determines the smallest eigenvalue
of the matrix A(f) = K + i2πfD+(2πf)2M + . . . . Sim-
ilarly to the case considered here, all higher eigenvalues
of A(f) possess positive real parts.
When ǫ crosses 0 and becomes negative, the autocor-
relation function (A6) develops unstable behavior, again
directed along the corresponding right eigenvector b of
K. In particular, one finds for the dispersion of the ex-
pressome at large t
E(δx(t)δxT (t)) ≈ E(z2(0))b·bT exp
(
2ǫt
(aT ·Db)
)
, (A7)
where E(z2(0)) is the dispersion of the projection z =
(δxT · b) of the expressome on the vector b, taken at
the initial moment of time. The displacements of the
expressome δx along the other orthogonal components
correspond to the dynamics of the gene network along
the eigenvectors, characterizing the modes with finite and
positive eigenvalues, and hence remain stable in time.
Thus, the quantity of interest in the critical regime
ǫ→ 0 is the projection of the expressome δx on the right
eigenvector b, z = (δxT · b), which satisfies the Langevin
equation
dz
dt
= v (z) + δF ′, (A8)
where v (z) is the “velocity”, characterizing the motion
along the z coordinate. Next to the origin the velocity
v(z) ≈ αz, where α = −ǫ/(aT ·Db). Here δF ′ = F/(aT ·
Db), is the stochastic force, such that E(δF ′(t)δF ′(t′)) =
∆δ(t− t′), and ∆ = (aT ·Ba)/(aT ·Db)3 is a property of
the fluctuations. Since the vector b is defined as eigen-
evector and subsequently is defined up to a factor, we can
always select its direction in such a way as to make the
collective coordinate z increase with the age. It means
that we can always limit our attention to the region z > 0
only.
Appendix B: Estimating mortality rates from the
stochastic dynamics of an expressome
So far we have only considered stochastic dynamics
of the expressome state vector δx of an organism. To
proceed with population properties, such as mortality,
we need to construct a statistical description for popula-
tions, ensembles of organisms. Let us consider a large
population of animals with the number of individuals
N(t = 0) = N0 ≫ 1, born at the same moment of time,
t = 0. The development and aging of the animals in the
population depends on the dynamics of the expression
levels x and can be naturally described in terms of the
probability density dN = N0P (x, t) dx, where P (x, t) is
the fraction of individuals within the population, char-
acterized by the gene expression levels from the interval
(x, x+dx), and estimated at the time t. Another quantity
of interest is the survival probability
S(t) =
ˆ
P (x, t) dx,
defined as the fraction of the animals, N(t)/N0, surviving
by the age t, relative to the initial size of the population
N0. The mortality rate can be found using the standard
definition M(t) = −(dS/dt)/S. In this Section we shall
explain how to estimate the probability density P (x, t),
the survival probability S(t), and the mortality rateM(t)
from the stochastic dynamics of the expressome state vec-
tor δx.
1. Estimating the probability density P (z, t)
a. Fokker-Planck equation
Following the arguments above we describe the process
of aging as the slow changes in gene expression levels
δx over time governed by the Langevin equation (A8).
The probability P (z, t) is the solution of the associated
Fokker-Planck equation [56]
∂P (z, t)
∂t
+
∂J (z, t)
∂z
= 0, (B1)
where
J (z, t) = v(z)P (z, t)− 1
2
∆
∂P (z, t)
∂z
is the probability flux along the direction z. We seek
the distribution function P (z, t) as the solution, corre-
sponding to the initial condition P (z, t = 0) = P0(z),
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and boundary conditions at z = 0 and large z. To ex-
clude the z < 0 region we place a reflecting wall at z = 0,
which corresponds to(
∂P (z, t)
∂z
)
z=0
= 0. (B2)
The suggested form of the boundary condition means
that the z > 0 and z < 0 regions are totally isolated
from each other.
We explore a Gaussian form of the initial condition in
the form
P0(z) = G (z) +G (−z) , (B3)
G (z) =
1√
2πσ0
e
−
(z−z0)
2
2σ2
0 ,
characterized by the initial displacement z0, and the dis-
tribution width, σ0. The probability distribution (B3) is
an even functions and hence satisfies the boundary condi-
tion for (B2) automatically. Therefore, the normalization
condition takes the form
∞ˆ
0
dzP0(z) = 1. (B4)
In fact, in many practical situations Eq. (B1) can be
solved without the the boundary condition (B2) using a
simpler form of the initial distribution P0(z) = G (z). In
this case the fraction of the animals
P− =
1
2
[
1− erf
(
z0√
2σ1
)]
, σ1 =
√
σ20 +
△
2α
,
will be, of course, lost to the unphysical region z < 0.
Therefore, the results of such a simplified calculation
could only be trusted once the “leak” is sufficiently small,
P− ≪ 1, or, equivalently, if z0 ≫ σ1. We distinguish be-
tween the two quantitatively different types of the initial
conditions: the “deterministic”,
z0 ≫ σ1, (B5)
and the “diffusive”, z0 ≪ σ1,forms respectively.
For sufficiently small values of z the “velocity” term in
the Langevin equation (A8) can be approximated by its
linear expansion
v (z) = αz. (B6)
For larger z the nonlinearities set in and we employ a
more general form
v (z) = αzφ (z) , (B7)
where φ (0) = 1 is chosen to match the asymptotic ex-
pression (B6) for small z. More specifically we expect
that the function φ (z) increases at z → ∞ fast enough,
so that that ln(z)/φ (z)→ 0 (see the discussion below).
Biological states characterized by extremely large val-
ues of z correspond to highly distorted expression pro-
files and therefore we assume, that the state z = ∞
is certainly associated with the death of the individual.
Therefore, a physically relevant choice of the boundary
condition at large z is
P (z →∞, t) = 0. (B8)
The Fokker-Planck equation (B1) with the boundary con-
dition in the form of Eq. (B8) cannot be solved exactly.
Fortunately, this is not really needed: a large amount of
useful information about the stochastic dynamics of the
expressome in relation to aging can be extracted from the
asymptotic behavior of the probability density P (z, t) in
a few physically interesting regimes. The following anal-
ysis of the solutions of Eq. (B1) is not, of course, new
and we loosely follow the results presented in [27, 57] in
the remaining of manuscript.
b. A toy model: absorbing wall at a large z = Z
Let us first collect a few well known results about the
solutions of Eq. (B1) for small z, where the drift velocity
v(z) can still be used in its linear form (B6). If, for
simplicity of the argument, the initial distribution is very
narrow, σ0 → 0 and z0 = 0 (G(z) ≈ δ(z)), then the
solution satisfying the boundary condition (B8) is
P (z, t) = 2G (z, 0, t) = 2
√
α
πX (t)∆
exp
[
− αz
2
X (t)∆
]
,
(B9)
where
G (z, z′, t) =
√
α
πX (t)∆
exp
[
−α (z − z
′eαt)
2
X (t)∆
]
is the Green function of Eq. (B1), and X (t) =
exp (2αt) − 1. Therefore, at sufficiently early times,
t . α−1, the effect of the drift term is negligible and
the behavior of z is described by the diffusion equation
with v(z) ≈ 0. This means that at least in the beginning
the solution is dominated by the effect of the random
force f(t) over the “deterministic” force −αz [27, 57].
Over time the deterministic force is taking over. It is
instructive to observe the relevant regimes of the solution
using a toy model first. To emulate the effect of the non-
linearity let us choose the form of the boundary condition
at large z in the form of a totally absorbing wall,
P (z = ±Z, t) = 0, (B10)
suggesting that the an organism dies whenever its z
reaches a certain threshold value Z. The solution (B9)
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remains valid for sufficiently small ages,
t .
1
α
ln
(
Z
√
α
∆
)
≡ tls, (B11)
before the appreciable fraction of the animals reaches the
z ∼ Z, and hence t = tls is of order of the lifespan in
the population. Often the life expectancy tls exceeds the
GRN instability time scale, tα ∼ 1/α, or
αZ2
∆
& 1. (B12)
It is shown below, that αZ
2
/∆ is the basic large parameter
of our model. Whenever the ratio of the time scales is suf-
ficiently large, the effects of the non-linearities are “weak”
and a complete analytical treatment of the problem be-
comes possible and yields a series of universal results.
Technically, to meet the boundary condition (B10) re-
quirement, we add a loss term at the position of the ab-
sorbing wall,−η (t) [δ (z − Z) + δ (z + Z)], where η (t) is
the Lagrange multiplier, an auxiliary function introduced
to enforce the constraint (B10). The analysis of the mod-
ified equation is straightforward and yields
P (z, t) = Φ (z, t)−
−
tˆ
0
[G (z, Z, t− t′) +G (z,−Z, t− t′)] η (t′) dt′, (B13)
where
Φ (z, t) =
+∞ˆ
−∞
G (z, z′, t)P0 (z
′) dz′.
If the non-linearity is weak or the wall is far from cur-
rent state of the system, i.e. whenever (B12) holds, then
G (Z,−Z, t− t′) ≪ G (Z,Z, t− t′), the function η (t′)
varies very slowly with age compared to G (Z,Z, t− t′),
and therefore
η (t) ≈ αZΦ (Z, t) . (B14)
For the case of Gaussian initial distribution (B3) we have
Φ(z, t) =
1√
2πσ (t)
[
e
−
(z−z(t))2
2σ2(t) + e
−
(z+z(t))2
2σ2(t)
]
, (B15)
where z (t) = z0 exp(αt), and the effective distribution
width increases exponentially with age
σ2 (t) = σ20 + σ
2X (t) , (B16)
where the combined quantity
σ =
√
σ20 +
∆
α
results from the initial probability density width broad-
ening by diffusion at small t.
c. Weak non-linearity limit, general case
Let us turn our attention back to the general form of
the non-linear drift velocity (B7).At sufficiently small z
function v(z) can be approximated by its linear expansion
v(z) ≈ αz and therefore Eq. (B1) can be studied in its
simplified form
∂P (z, t)
∂t
+
∂
∂z
[
αzP (z, t)− 1
2
∆
∂P (z, t)
∂z
]
= 0. (B17)
We introduce a characteristic length scale z ∼ Z, where
the linear approximation to v(z) fails. The age when
z ∼ Z will correspond roughly to the lifespan of the or-
ganism, since, according to our assumptions, v(z) grows
fast enough at large z and the point z =∞ is reached in
a finite time.
This linearized equation can be solved exactly with
initial distribution (B3) and boundary condition (B8):
P (z, t) =
1√
2πσ
exp
{
−αt− (ze
−αt − z0)2
2σ2
}
(B18)
which would be a rightful approximation for solution of
Eq. (B1) in time region t≪ tls.
In the same time, at t ≫ α−1 , irrespectively of the
specific form of the nonlinearity, one can neglect the dif-
fusion and set ∆ = 0. This means that the dynamics
of the expressome is dominated by the drift term and is,
therefore, deterministic. Accordingly, Eq. (B1) can be
transformed into
∂P (z, t)
∂t
+
∂
∂z
[v (z)P (z, t)] = 0. (B19)
One of the consequences of Eq.(B19) is the fact that if
a specimen is observed with an expressome state, cor-
responding to z ≫
√
∆/α, then the remaining life ex-
pectancy, or the time-to-death, for the animal is
τ (z) =
∞ˆ
z
dz′
v (z′)
, (B20)
and is finite. The integral on the r.h.s. is logarithmically
divergent for the chosen type of non-linearity B7, which
means that
τ(z) =
1
α
ln
(
1
z
)
+ τ˜ (z) ,
and
lim
z→0
τ˜ (z) = const
is finite.
The solution of Eq.(B19) takes form P (z, t) =
P (z, ξ) = C(ξ)/ν(z), where ξ = t + τ(z) and C(ξ) is a
function dependent on initial distribution and boundary
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conditions. One way to find it is to match the solutions
of Eqs. (B17) and (B19) at some intermediate age t1,
lying in time region, where both equations can be used.
Indeed, since normally α−1 ≪ tls , we can use any t1
such that
α−1 ≪ t1 ≪ tls (B21)
as the matching point. The age range corresponds to√
∆/α . z1 . Z interval. As the result, we obtain a
closed form solution, applicable for deterministic initial
condition (B5) and boundary condition (B8) for all ages
t & 1/α
P (z, t) =
αk (z)√
2πσv (z)
exp
{
−αt− [k (z) e
−αt − z0]2
2σ2
}
.
(B22)
Here
Z˜ = lim
z→0
eατ˜(z) ∼ Z, (B23)
and
k (z) = Z˜ exp [−ατ (z)] (B24)
is auxiliary function with known asymptotic forms for
the advanced (τ (z)→ 0)
k (z)→ Z˜ at z →∞, (B25)
and the early (τ (z)→∞)
k (z)→ 0 at z → 0 (B26)
ages.
Let us turn to a more specific case of an arbitrary poly-
nomial non-linearity
φ (z) = 1 +
( z
Z
)β
(B27)
with β > 0. The length scale here characterizes the non-
linearity strength and hence large values of Z correspond
to the weak non-linearity limit (B6). In accordance with
the earlier definitions, it can be shown that Z˜ equals Z,
and the remaining lifespan is
τ (z) =
1
α
ln
{[
Zβ + zβ
]1/β
z
}
,
and the probability distribution function takes the form
of Eq. (B22) with with k (z) = z/
[
1 + (z/Z)β
]1/β
.
The absorbing wall at z = Z situation, considered in
the previous section, formally corresponds to β = ∞.
Interestingly, the solution is still valid, k(z) = z every-
where, if not immediately close to the wall, i.e. Eq. (B22)
matches the exact expression (B13) for all z . Z. Hence
we can conclude that the derived form of the probabil-
ity density is universal, holds for an arbitrary form of
the non-linearity, allowing for a finite lifespan. A specific
form of the non-linearity is not important, all the infor-
mation about the non-linear terms can be compressed
into the length scale Z, being the single important pa-
rameter defining the lifespan and the form of the distri-
bution function in the population.
Let us finish the section by computing the fraction of
the animals, surviving by the age t. According to the
definition,
S (t) =
+∞ˆ
0
dzP (z, t) =
=
1√
2πσ
Zˆ
0
dk exp
{
−αt− [k (z) e
−αt − z0]2
2σ2
}
=
=
1√
π
y2ˆ
y1
dye−y
2
,
where, for αt≫ 1,
y2 =
Ze−αt − z0√
2σ
, y1 =
−z0√
2σ
.
That would lead us to expression
S (t) =
1
2
{
erf
[
z0√
2σ
]
+ erf
[
Ze−αt − z0√
2σ
]}
. (B28)
We also note, that
+∞ˆ
0
dzP (z, t) < 1,
since the animals die and hence disappear at the infinity.
2. Estimating the first passage time, the survival
probabilities, and the average lifespan
In the case under consideration, a more interesting
quantity to calculate and analyze is not the probability
density P (z, t) itself, but a so-called first passage time
distribution function PFPT(t) [58, 59]. The reason is
that the probability density P (z, t) represents a sum over
all possible stochastic trajectories z(t), including those
which pass the effective threshold z = Z and then return
back. On the other hand, by definition, PFPT(T ) is a
probability for a given stochastic trajectory z = z(t) to
pass the threshold z = Z at t = T for the very first time.
As such, it does not take into account trajectories which
then re-enter the allowed domain of z.
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When the “deterministic” form of the initial condition
is chosen, the first passage time distribution function is
given by
PFPT(t) = −S˙ (t) =
=
√
α
π∆
2αZe2αt
[X (t)]3/2
exp
[
− αZ
2
X (t)∆
]
. (B29)
The function (B29) grows exponentially at small t .
α−1, possesses a distinct maximum at tmax = tls =
α−1 ln
[(
αZ2
∆
)1/2]
, with its width δt ∼ α−1 near the
maximum and finally decays as e−αt at t≫ tmax, see Fig.
5. Computing the first passage time distribution function
also allows one to easily estimate the survival probability
S(t), using the prescription PFPT (t) = −dS(t)/dt. From
Eq. (B29) we find
S(t) = erf
[√
αZ2
2∆X(t)
]
, (B30)
In the regime α−1 < t . tls , also known as Suzuki scaling
[27, 57],equation for PFPT(t) reduces to
PFPT(t) ≈ 2αZ
( α
2π∆
)1/2
exp
(
−αt− αZ
2
2∆
e−2αt
)
.
(B31)
If the non-linearity is small, the center of the originally
narrow distribution in the z-space follows the well defined
trajectory z¯ (t) = z0 exp (αt). At t = t0 = α
−1 ln (Z/z0)
it achieves the absorbing wall, which means that the aver-
age lifespan in the population described by the distribu-
tion is also tls ≈ t0. This result follows immediately from
(B28) and the exact definition of the average lifespan
tls =
∞ˆ
0
dtS (t) . (B32)
From Eq. (B31) we find
S(t) ≈ erf
[(
αZ2
2∆
)1/2
e−αt
]
, (B33)
expression precise up to terms, exponentially small at
αZ2
∆ ≫ 1, i.e., when a species is considered long-lived
compared to the characteristic time scales of molecular
dynamics in the cell, see the next Subsection. The func-
tion (B33), initially exponentially close to 1, then falls off
quickly (as we shall see below, this fall-off corresponds to
an exponentially growing mortality rate) and finally ap-
proaches zero as exp(−αt) at t≫ tls.
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Figure 5: The first passage time distribution function
PFPT(t) (in units of 2α) and the survival probability
S(t) as a function of time 2αt; αZ
2
∆ = 1000.
3. Behavior of the mortality rate
As usual, the mortality rate is defined as M(t) =
−S−1 · dS/dt, so that one has precisely
M(t) =
PFPT(t)
S(t)
. (B34)
Once again, for the very narrow initial distribution (B8),
σ0 → 0 and z0 = 0 (G(z) ≈ δ(z)), we find, that
M (t) =
√
α
π∆
2αZe2αt
[X (t)]
3/2
exp
[
− αZ
2
X (t)∆
]
×
×
{
erf
[√
αZ2
2X(t)∆
]}
.−1 (B35)
For a more realistic determenistic form of the probability
distribution at the origin B5 the solution is still possible,
and for sufficiently advanced ages, t≫ α−1, we obtain
M (t) =
Zα
σ
√
2
π
exp
[
− (Ze
−αt − z0)2
2σ2
− αt
]
×
×
{
1 + erf
[
Ze−αt − z0√
2σ
]}−1
, (B36)
once the non-linearity is sufficiently weak, as commanded
by the condition (B12).
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a. Vanishing mortality at very early ages t≪ α−1
At sufficiently early ages t ≪ α−1 behavior of z is
dominated by the effect of the random force f(t) over
the “deterministic” force v(z) [27, 57]. Accordingly, the
state variable and its fluctuations grow exponentially
with age. This conclusion is confirmed by the analysis
of senescence-associated transcriptional dynamics. It is
worth emphasizing that the characteristic time scale of
the stochastic growth of the expressome is ∼ α−1. It thus
depends only on the morphological properties of the GRN
and does not depend on the genotoxic stress amplitude
∆ at all.
At very early ages t≪ α−1 the first passage time dis-
tribution function is exponentially strongly suppressed:
PFPT(t) ≈ 2αZ
(2αt)3/2
( α
2π∆
)1/2
exp
(
− Z
2
4∆t
)
. (B37)
In this regime the survival probability S(t) remains ex-
ponentially close to 1:
S(t) ≈ 1− 2√
π
(
4∆t
Z2
)2
exp
(
− Z
2
4∆t
)
.
Therefore, the mortality rate remains exponentially close
to 0, and one approximately has M(t) ≈ PFPT(t). In our
opinion, this behavior might explain relatively small mor-
tality, often observed in cohorts at very early ages. We
note that the behavior of the mortality rate in this regime
is not universal as it strongly depends on the amplitude
∆ of stochastic genotoxic stress.
b. Gompertz behavior at later ages t ∼ α−1
As was explained above, as the age increases, the effect
of the stochastic force δF in Eq. (A4) quickly becomes
negligible in comparison to the effect of the “determin-
istic” force −Kδx; the stochastic regime is changed by
the drift motion at t ∼ α−1. Correspondingly, the be-
havior (B37) quickly changes when t & α−1, yielding a
Gompertz-like dependence of the mortality rate on age:
M (t) ≈M0 exp (γt), where the exponent
γ (t) =
d
dt
lnM (t) ∼ αZ
2X˙ (t)
X2 (t)∆
∼ ααZ
2
∆
≫ α
is found from Eq. (B35) and is much greater than the
GNR instability parameter α.
c. Universal Gompertz behavior in the regime of Suzuki
scaling
At even later times of the order t ∼ tls, when the
regime of Suzuki scaling is realized, we also find a uni-
versal Gompertz behavior. As was explained above, the
first passage time probability distribution PFPT reaches
a maximum at tmax = α
−1 ln Λ = tls, where Λ =
α1/2Z
∆1/2
,
and its half-width near the the maximum is of the order
α−1, as in Fig. 5. By the time t ∼ tmax the argument
of the error function in Eq. (B33) is already sufficiently
small for it to be expanded. One thus has
S(t) ≈ 2√
π
Λe−αt − 2
3
√
π
Λ3 exp(−3αt) + . . . .
On the other hand, one finds for PFPT(t) in the same
regime
PFPT(t) =
2αΛ√
π
e−Λ
2 exp(−2αt)e−αt,
so that approximately
M(t) ≈ αe−Λ2 exp(−2αt).
Introducing t = tmax + δt one finally finds at small δt .
(2α)−1
M(t) ≈ e−1/2αeαδt ≈ 0.61αeαδt. (B38)
Thus, the Gompertz law with the universal exponent α−1
is realized at times tmax−(2α)−1 . t . tmax+(2α)−1. We
again emphasize that the Gompertz aging rate α depends
only on the properties of the GRN under consideration
and does not depend on stress. In fact, the very same
conclusion holds for the Gaussian initial distribution case
(B36).
d. Mortality deceleration at late ages
Finally, at t≫ tmax both the first passage time distri-
bution function (B29) and the survival probability (B30)
decay exponentially. This corresponds to an asymptot-
ically constant behavior of the mortality rate in both
cases, (B35) and (B36):
M(t) ≈ α, (B39)
see Fig. 6. For late t, corrections to the leading constant
term become exponentially small with time. The exis-
tence of mortality plateau in models of the type (A4) is
known in literature [60, 61].
4. Concluding remarks on aging regimes
phenomenology
a. The unstable case, Gompertz limit, αZ2/∆≫ 1
This case includes situations with a very weak non-
linearity in the Fokker-Planck equation (B1) and corre-
sponds to a very high toxicity threshold Z as compared to
the characteristic amplitude of fluctuations of the stress
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Figure 6: The mortality rate M(t) for the case of the
“diffusive” initial condition; αZ2/∆ = 1000. The
maximum of PFPT(t) is reached at 2αt ≈ 6.9.
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Figure 7: The mortality rate as a function of age from
the very large cohorts study, medflies, males and
females from [21].
factors ∆. As was explained above, we expect a species
with such a GRN to be relatively long-lived, as the aver-
age life expectancy (B11) is logarithmically larger than
the inverse Gompertz exponent α−1. Four very distinct
regimes of mortality exist for such species: (a) the regime
of small mortality at early ages, (b) a Gompertz regime
with the Gompertz exponent∼ α2Z2/∆≫ α, (c) a Gom-
pertz regime with a universal Gompertz exponent α and
finally (d) a regime of constant mortality M∞ = α. On
the other hand, if indeed Z ≫ σ0, the initial Gompertz
exponent in regime (b) is very large, and a population of
moderate size simply dies out before the regime of mor-
tality slowing-down is observed.
b. The unstable case, short lifespan limit, αZ2/∆ & 1
There are again four distinct regimes (a-d) of aging
discussed above, with that difference that the regime
(b) is hard to observe or unobservable, so a Gompertz
regime (c) with the exponent ∼ α is observed. Clearly,
the regimes (c) and (d) are closely connected to each
other in the sense, described above, and there is a strong
correlation between the observed value of the Gompertz
exponent and the mortality rate M∞ at late ages. This,
as it seems, is what we observe e.g. in experiments with
extremely large cohorts study of medflies, males and fe-
males from [21], see Fig. 7. A relatively short aver-
age lifespan of such species is comparable to the value of
Gompertz exponent.
c. The stable case, α < 0
In this case, arguably the most interesting to consider,
the effective potential V (z) of the Langevin equation pos-
sesses a local minimum, separated from the roll-down to
z → ∞ by a potential barrier, see Fig. 1B of the main
text. There exists a single regime of aging realized for
the GRN of this type. It is characterized by a constant
mortality rateM∞, its value being determined by the ex-
ponentially small Kramers probability of passage through
the barrier[62]. If a GRN with such properties indeed ex-
ists in nature, it would correspond to a species with neg-
ligible senescence. We leave the in-depth study of this
regime for a future work.
Appendix C: Gene annotation
To analyze the vector b, obtained from the transcrip-
tome of D. melanogaster [19], we have performed a gene
set enrichment analysis for the components of vector b us-
ing “Parent-Child-Intersection” GO enrichment analysis
procedure described in [63]. This method considers genes
in the background if they are present in all parent terms
of the term of interest. Since the values in vector b can
be both positive and negative, lists of positive and neg-
ative leading components were analyzed separately. We
studied the dependence of significantly enriched GO cate-
gories on the number of the leading components selected.
The list of enriched GO categories appeared to be stable
in a broad range of number of the leading components, so
200 positive and 200 negative leading components from
21
GO-stability regions were analyzed.We employed an ad-
justed p-value (Benjamini-Hochberg) cutoff of 0.05.
We have performed KEGG pathway enrichment anal-
ysis of the human orthologs of the genes corresponding
to the most significant components of vector b, computed
from the transcriptome of D. melanogaster [19]. A one-
sided Fischer exact test was performed, after which an
adjusted p-value (Benjamini-Hochberg) cutoff of 0.05 was
employed. We used OrthoDB v.7 [64] to map fly genes
to corresponding human orthologs.
[1] Skulachev, V. The programmed death phenomena, aging,
and the Samurai law of biology. Exp. Gerontol. 36, 995–
1024 (2001).
[2] Longo, V. D., Mitteldorf, J. & Skulachev, V. P. Pro-
grammed and altruistic ageing. Nat. Rev. Genet. 6, 866–
72 (2005).
[3] Partridge, L. & Gems, D. Mechanisms of ageing: public
or private? Nat. Rev. Genet. 3, 165–75 (2002). URL
http://dx.doi.org/10.1038/nrg753 .
[4] Sinclair, D. A. & Oberdoerffer, P. The
ageing epigenome: damaged beyond repair?
Ageing Res. Rev. 8, 189–98 (2009). URL
http://www.sciencedirect.com/science/article/pii/S1568163709000245.
[5] Gladyshev, V. N. On the cause of aging and control of
lifespan: heterogeneity leads to inevitable damage accu-
mulation, causing aging; control of damage composition
and rate of accumulation define lifespan. Bioessays 34,
925–9 (2012).
[6] Gladyshev, V. N. The origin of aging: imperfectness-
driven non-random damage defines the aging process and
control of lifespan. Trends Genet. 29, 506–12 (2013).
[7] Orgel, L. E. Ageing of Clones of Mammalian Cells. Na-
ture 243, 441–445 (1973).
[8] Blagosklonny, M. V. Aging and immortality: quasi-
programmed senescence and its pharmacologic inhibi-
tion. Cell Cycle 5, 2087–2102 (2006).
[9] Blagosklonny, M. V. & Hall, M. N. Growth and aging: a
common molecular mechanism. Aging 1, 357 (2009).
[10] de Magalhães, J. P. Programmatic features of aging
originating in development: aging mechanisms beyond
molecular damage? FASEB J. 26, 4821–6 (2012). URL
http://www.fasebj.org/content/26/12/4821.short.
[11] Kirkwood, T. B. L. Evolution of ageing. Nature 270,
301–304 (1977).
[12] Kirkwood, T. B. & Austad, S. N. Why do we age? Nature
408, 233–8 (2000).
[13] Williams, G. Pleiotropy, natural selection, and the evolu-
tion of senescence. Science’s SAGE KE 2001, 13 (2001).
[14] Medawar, P. An unsolved problem of biology (College,
1952).
[15] Shmookler Reis, R. J. Model systems for aging research:
syncretic concepts and diversity of mechanisms. Genome
31, 406–412 (1989).
[16] Gladyshev, V. N. Aging: progressive decline in fitness
due to the rising deleteriome adjusted by genetic, envi-
ronmental, and stochastic processes. Aging cell (2016).
[17] Kogan, V., Molodtsov, I., Menshikov, L. I., Shmook-
ler Reis, R. J. & Fedichev, P. Stability analysis of a
model gene network links aging, stress resistance, and
negligible senescence. Scientific Reports 5, 13589 EP –
(2015). URL http://dx.doi.org/10.1038/srep13589 .
[18] Antoulas, A. C. Approximation of Large-Scale Dynamical
Systems (SIAM, 2009).
[19] Pletcher, S. D. et al. Genome-wide transcript profiles in
aging and calorically restricted Drosophila melanogaster.
Current Biology 12, 712–723 (2002).
[20] Avanesov, A. S. et al. Age-and diet-associated
metabolome remodeling characterizes the aging process
driven by damage accumulation. eLife 3 (2014).
[21] Vaupel, J. W. et al. Biodemographic trajectories of
longevity. Science 280, 855–860 (1998).
[22] Horvath, S. Dna methylation age of human tissues and
cell types. Genome biology 14, R115 (2013).
[23] Balleza, E. et al. Critical dynamics in genetic regulatory
networks: examples from four kingdoms. PLoS One 3,
e2456 (2008).
[24] Krotov, D., Dubuis, J. O., Gregor, T. & Bialek, W.
Morphogenesis at criticality. Proceedings of the National
Academy of Sciences 111, 3683–3688 (2014).
[25] Fiedler, B. E. Handbook of Dynamical Systems, Volume
2 (Gulf Professional Publishing, 2002).
[26] Seydel, R. Practical Bifurcation and Stability Analysis,
vol. 1 (Springer Science & Business Media, 2009).
[27] Suzuki, M. Passage from an initial unstable state to
a final stable state. In Advances in Chemical Physics,
Volume 46, 195–276 (John Wiley & Sons, 2009). URL
http://books.google.com/books?hl=en&lr=&id=6uAY7tkKEVkC&pgis
[28] Brown, J. B. et al. Diversity and dynamics of the
drosophila transcriptome. Nature (2014).
[29] Moskalev, A. et al. Mining gene expression data for
pollutants (dioxin, toluene, formaldehyde) and low dose
of gamma-irradiation. PLoS ONE 9, e86051 (2014). URL
http://dx.doi.org/10.1371%2Fjournal.pone.0086051.
[30] Morse, C. Does variability increase with age? an archival
study of cognitive measures. Psychol Aging 8, 156–64
(1993).
[31] Rother, P. The aging changes of biological variability
(author’s transl). ZFA 33, 463–6 (1978).
[32] Khalyavkin, A. & Krutko, V. Aging is a simple de-
privation syndrome driven by a quasi-programmed pre-
ventable and reversible drift of control system set points
due to inappropriate organism-environment interaction.
Biochemistry (Moscow) 79, 1133–1135 (2014).
[33] Arlia-Ciommo, A., Piano, A., Leonov, A., Svistkova, V.
& Titorenko, V. I. Quasi-programmed aging of bud-
ding yeast: a trade-off between programmed processes
of cell proliferation, differentiation, stress response, sur-
vival and death defines yeast lifespan. Cell Cycle 13,
3336–3349 (2014).
[34] Blagosklonny, M. V. Answering the ultimate question"
what is the proximal cause of aging?". Aging 4, 861–877
(2012).
[35] Blagosklonny, M. V. MTOR-driven quasi-programmed
aging as a disposable soma theory. Cell Cycle 12, 1842–
1847 (2013).
[36] Gompertz, B. On the nature of the function expressive
of the law of human mortality, and on a new mode of
determining the value of life contingencies. Philosophical
22
transactions of the royal society of London 115, 513–583
(1825).
[37] Katzenberger, R. J. et al. A drosophila model of closed
head traumatic brain injury. Proceedings of the National
Academy of Sciences 110, E4152–E4159 (2013).
[38] Tacutu, R. et al. Human ageing genomic resources: Inte-
grated databases and tools for the biology and genetics of
ageing. Nucleic acids research 41, D1027–D1033 (2013).
[39] Khan, I. & Prasad, N. The aging of the immune response
in Drosophila melanogaster. The Journals of Gerontology
Series A: Biological Sciences and Medical Sciences 68,
129–135 (2013).
[40] Zhou, D. et al. Mechanisms underlying hypoxia tolerance
in Drosophila melanogaster : hairy as a metabolic switch.
PLoS genetics 4, e1000221 (2008).
[41] Poynter, M. E. & Daynes, R. A. Peroxisome proliferator-
activated receptor α activation modulates cellular redox
status, represses nuclear factor-κb signaling, and reduces
inflammatory cytokine production in aging. Journal of
Biological Chemistry 273, 32833–32841 (1998).
[42] Gómez-Valadés, A. G. et al. Overcoming diabetes-
induced hyperglycemia through inhibition of hepatic
phosphoenolpyruvate carboxykinase (gtp) with rnai.
Molecular Therapy 13, 401–410 (2006).
[43] Tazearslan, Ç., Ayyadevara, S., Bharill, P. & Shmook-
ler Reis, R. J. Positive feedback between transcriptional
and kinase suppression in nematodes with extraordinary
longevity and stress resistance. PLoS Genet 5, e1000452
(2009).
[44] Hanson, R. W. & Hakimi, P. Born to run; the story of
the pepck-c mus mouse. Biochimie 90, 838–842 (2008).
[45] American medical association, resolution 420 (a-13):
recognition of obesity as a disease. In Proceedings of the
House of Delegates 162nd Annual Meeting (2013).
[46] Ren, C., Webster, P., Finkel, S. E. & Tower, J. Increased
internal and external bacterial load during Drosophila ag-
ing without life-span trade-off. Cell metabolism 6, 144–
152 (2007).
[47] Jones, O. R. et al. Diversity of ageing across the tree of
life. Nature 505, 169–173 (2014).
[48] Finch, C. E. Longevity, senescence, and the genome (Uni-
versity of Chicago Press, 1994).
[49] Buffenstein, R. The naked mole-rat: a new long-living
model for human aging research. The Journals of Geron-
tology Series A: Biological Sciences and Medical Sciences
60, 1369–1377 (2005).
[50] Kim, E. B. et al. Genome sequencing reveals insights into
physiology and longevity of the naked mole rat. Nature
479, 223–227 (2011).
[51] Jeannette Loram, A. B. Age-related changes in gene ex-
pression in tissues of the sea urchin Strongylocentrotus
franciscanus. Mechanisms of Ageing and Development
133, 338–347 (2012).
[52] Kadish, I. et al. Hippocampal and cognitive aging across
the lifespan: a bioenergetic shift precedes and increased
cholesterol trafficking parallels memory impairment. The
Journal of Neuroscience 29, 1805–1816 (2009).
[53] Schervish, M. J. Theory of Statistics, vol. 21 (Springer
New York, 2011).
[54] Podolsky, D. & Turitsyn, K. Critical slowing-down as in-
dicator of approach to the loss of stability. arXiv preprint
arXiv:1307.4318 (2013).
[55] Podolsky, D. & Turitsyn, K. Random load fluctuations
and collapse probability of a power system operating near
codimension 1 saddle-node bifurcation. In Power and
Energy Society General Meeting (PES), 2013 IEEE, 1–5
(IEEE, 2013).
[56] Zwanzig, R. Nonequilibrium Statistical Mechanics (Ox-
ford University Press, USA, 2001).
[57] Suzuki, M. Scaling theory of transient phe-
nomena near the instability point. Journal
of Statistical Physics 16, 11–32 (1977). URL
http://link.springer.com/10.1007/BF01014603.
[58] Redner, S. A Guide to First-Passage Processes (Cam-
bridge University Press, 2001).
[59] Aalen, O., Borgan, O. & Gjessing, H. Survival and Event
History Analysis: A Process Point of View (Springer,
2008).
[60] Weitz, J. S. & Fraser, H. B. Explaining mortality rate
plateaus. Proc. Natl. Acad. Sci. U. S. A. 98, 15383–6
(2001).
[61] Steinsaltz, D. & Evans, S. N. Markov mortality mod-
els: implications of quasistationarity and varying initial
distributions. Theor. Popul. Biol. 65, 319–37 (2004).
[62] Lifshitz, E. & Pitaevskii, L. Physical kinetics (1995).
[63] Grossmann, S., Bauer, S., Robinson, P. N. & Vingron,
M. Improved detection of overrepresentation of gene-
ontology annotations with parent–child analysis. Bioin-
formatics 23, 3024–3031 (2007).
[64] Waterhouse, R. M., Tegenfeldt, F., Li, J., Zdobnov, E. M.
& Kriventseva, E. V. Orthodb: a hierarchical catalog
of animal, fungal and bacterial orthologs. Nucleic acids
research 41, D358–D365 (2013).
23
[Competing Interests] The authors declare that they
have no competing financial interests.
[Author Contrbutions] All authors contributed equally
to this work.
[Correspondence] Correspondence and requests for
materials should be addressed to P.O.F. (email: pe-
ter.fedichev@gmail.com)
